Li CP, Jia WW, Chu Y, Menge F, Speer T, Reissfelder C, Hohenberger P, Jakob J, Yang C. Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries using GPT-4o Enhanced with German Evidence-Based Guidelines,Oncol Res Treat,Oncol Res Treat. 2025 Feb 28:1-18. doi: 10.1159/000544978. Online ahead of print.

Wang X, Ye J, Liu D, Yan L, Li S, Lv A, Li C, Wu J, Qiu H, Hao C. Bibliometric analysis of liposarcomas treatment from 2004 to 2023,J Cancer Res Clin Oncol,J Cancer Res Clin Oncol. 2025 Jan 24;151(2):47. doi: 10.1007/s00432-025-06094-0.

Li CP, Jakob J, Menge F, Reissfelder C, Hohenberger P, Yang C. Comparing ChatGPT-3.5 and ChatGPT-4's alignments with the German evidence-based S3 guideline for adult soft tissue sarcoma,iScience,iScience. 2024 Nov 28;27(12):111493. doi: 10.1016/j.isci.2024.111493. eCollection 2024 Dec 20.

Wang X, Ye J, Wu Y, Zhang H, Li C, Liu B, Guan X, Tian X, Jia W, Liu Q, Li S, Sun R, Liu D, Xue G, Wang Z, Yan L, Lv A, Wu J, Qiu H, Hao C. Integrated lipidomics and RNA-seq reveal prognostic biomarkers in well-differentiated and dedifferentiated retroperitoneal liposarcoma,Cancer Cell Int,Cancer Cell Int. 2024 Dec 18;24(1):404. doi: 10.1186/s12935-024-03585-x.

Jia WW, Wu JH, Yang C, Liu DN, Wang XP, Sun RZ, Li CP, Hao CY. An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors,World J Surg Oncol,World J Surg Oncol. 2024 Nov 14;22(1):303. doi: 10.1186/s12957-024-03585-1.

Jia W, Wu J, Zhang H, Wu Y, Liu D, Wang Z, Wang X, Li C, Hao C. Advancing treatment efficacy: combined therapy of eribulin, anlotinib, and camrelizumab in advanced or metastatic retroperitoneal liposarcoma,Ther Adv Med Oncol,Ther Adv Med Oncol. 2024 Sep 10;16:17588359241276968. doi: 10.1177/17588359241276968. eCollection 2024.

Xue GQ, Li CP, Lv A, Wu JH, Tian XY, Qiu H, Hao C. Prognostic Nutritional Index (PNI): A More Promising Nutritional Predictor for Patients Undergoing Surgery for Retroperitoneal Liposarcoma,Cancer Manag Res,Cancer Manag Res. 2024 Aug 13;16:1021-1030. doi: 10.2147/CMAR.S474801. eCollection 2024.

Xue G, Wang X, Liu B, Li C, Lv A, Tian X, Wu J, Qiu H, Hao C. Surgical outcomes of major vascular resection for retroperitoneal liposarcoma from a high?volume sarcoma center: a propensity score matching analysis,J Cancer Res Clin Oncol,J Cancer Res Clin Oncol. 2024 Jul 9;150(7):343. doi: 10.1007/s00432-024-05871-7.

Xue G, Wang Z, Liu B, Li C, Lv A, Tian X, Wu J, Qiu H, Hao C. Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis,Int J Clin Oncol,Int J Clin Oncol. 2024 Apr 23. doi: 10.1007/s10147-024-02530-2. Online ahead of print.

Liu DN, Li CP, Li HW, Wang HY, Tian XY, Hao CY. Volume-based (18)F-FDG PET/CT predicts prognosis and outcome of active surveillance for intra-abdominal desmoid tumor,Abdom Radiol (NY),Abdom Radiol (NY). 2024 Mar;49(3):958-963. doi: 10.1007/s00261-023-04145-z. Epub 2024 Jan 21.

Liu DN, Jia WW, Wang HY, Wu JH, Li CP, Hao CY. Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study,BMC Surg,BMC Surg. 2023 Jul 4;23(1):189. doi: 10.1186/s12893-023-02087-3.

Wu J, Li C, Liu B, Liu Q, Liu D, Wang Z, Wang X, Jia W, Tian X, Hao C. Efficacy and safety of anlotinib plus camrelizumab in treating retroperitoneal soft tissue sarcomas: a single-center retrospective cohort study,Ann Transl Med,Ann Transl Med. 2023 Mar 15;11(5):212. doi: 10.21037/atm-23-460.

Lv A, Liu DN, Wang Z, Li CP, Liu BN, Liu Q, Tian XY, Hao CY. Short- and long-term surgical outcomes of pancreatic resection for retroperitoneal sarcoma: A long-term single-center experience of 90 cases,J Surg Oncol,J Surg Oncol. 2023 Mar;127(4):633-644. doi: 10.1002/jso.27160. Epub 2022 Nov 28.

Li Y, Wu JH, Li CP, Liu BN, Tian XY, Qiu H, Hao CY, Lv A. Multidimensional characteristics, prognostic role, and preoperative prediction of peritoneal sarcomatosis in retroperitoneal sarcoma,Front Oncol,Front Oncol. 2022 Oct 27;12:950418. doi: 10.3389/fonc.2022.950418. eCollection 2022.

Wang Z, Wu JH, Li CP, Lv A, Qiu H, Tian XY, Liu BN, Hao CY. Patients with first recurrent retroperitoneal sarcoma that can be macroscopically completely resected can achieve comparable outcomes with that of primary patients after en bloc resection of tumor and adjacent organs,Front Surg,Front Surg. 2022 Sep 7;9:956384. doi: 10.3389/fsurg.2022.956384. eCollection 2022.

Zhou L, Xiao WM, Li CP, Gao YW, Gong WJ, Lu GT. Impact of Fatty Pancreas on Postoperative Pancreatic Fistulae: A Meta-Analysis,Front Oncol,Front Oncol. 2021 Dec 1;11:622282. doi: 10.3389/fonc.2021.622282. eCollection 2021.

Li Y, Lv A, Wu J, Li C, Liu B, Tian X, Qiu H, Hao C. Macroscopically complete excision is a beneficial strategy for selected patients with peritoneal sarcomatosis,Biosci Trends,Biosci Trends. 2022 Jan 23;15(6):382-389. doi: 10.5582/bst.2021.01421. Epub 2021 Nov 26.

Liu B, Wu J, Li C, Li Y, Qiu H, Lv A, Liu Q, Liu D, Wang Z, Hao C. The role of coeliac axis resection in resected ductal adenocarcinoma of the distal pancreas: A result of tumour topography or a prognostic factor?,Pancreatology,Pancreatology. 2022 Jan;22(1):112-122. doi: 10.1016/j.pan.2021.11.001. Epub 2021 Nov 3.

Xue GQ, Li CP, Lv A, Tian XY, Wu JH, Qiu H, Hao CY. Predictive Value of Preoperative Controlling Nutritional Status Score Combined with Fibrinogen-Albumin Ratio in Postoperative Local Recurrence-Free Survival of Patients with Retroperitoneal Liposarcoma,Cancer Manag Res,Cancer Manag Res. 2021 Aug 6;13:6157-6167. doi: 10.2147/CMAR.S307920. eCollection 2021.

李成鹏, 郝纯毅. 积极推动我国腹膜后肉瘤临床研究开展的思考,外科理论与实践,2022, (06): 495 -499